MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517049521 A) filed by Artus Therapeutics, Inc.; and Institute For Stem Cell Science And Regenerative Medicine, Allston, U.S.A., on May 22, for 'therapeutic agents for enhancing epithelial and/or endothelial barrier function.'
Inventor(s) include Vemula, Praveen, Kumar; Terrett, Nicholas, Kenneth; Jagadeesan, Sakthimala; and Ravula, Venkatesh.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel compounds and compositions thereof. The compositions are useful in the treatment of an epithelial or endothelial barrier dysfunction disorder in a subject."
The patent application was internationally filed on Oct. 25, 2023, under International application No.PCT/US2023/077699.
Disclaimer: Curated by HT Syndication.
